Epstein Barr Virus Negative Marginal Zone Lymphoma (MZL): A Unique Monomorphic Post-Transplant Lymphoproliferative Disorder (PTLD)

被引:0
|
作者
Galera, Pallavi [1 ]
Gong, Shunyou [2 ]
Swan, Niall [3 ]
Flavin, Richard [4 ]
Savage, Natasha [5 ]
Wang, Huan-You [6 ]
Saksena, Annapurna [7 ]
Xi, Liqiang [8 ]
Raffeld, Mark [9 ]
Pittaluga, Stefania [10 ]
Jaffe, Elaine [8 ]
机构
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA
[3] St Vincents Univ Hosp, Elm Pk, Dublin, Ireland
[4] St James Hosp, Dublin, Ireland
[5] Med Coll Georgia, Augusta, GA 30912 USA
[6] Univ Calif San Diego, La Jolla, CA 92093 USA
[7] NIH, Bldg 10, Bethesda, MD 20892 USA
[8] NCI, NIH, Bethesda, MD 20892 USA
[9] NCI, Bethesda, MD 20892 USA
[10] NIH, Washington, DC USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1371
引用
收藏
页码:1291 / 1292
页数:2
相关论文
共 50 条
  • [31] EBV-Positive Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in the Post-Transplant Setting: A Distinct Type of Monomorphic Post-Transplant Lymphoproliferative Disorder?
    Gibson, S. E.
    Swerdlow, S. H.
    Craig, F. E.
    Surti, U.
    Cook, J. R.
    Nalesnik, M. A.
    Lowe, C.
    Wood, K. M.
    Bacon, C. M.
    MODERN PATHOLOGY, 2011, 24 : 298A - 298A
  • [32] EBV-Positive Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in the Post-Transplant Setting: A Distinct Type of Monomorphic Post-Transplant Lymphoproliferative Disorder?
    Gibson, S. E.
    Swerdlow, S. H.
    Craig, F. E.
    Surti, U.
    Cook, J. R.
    Nalesnik, M. A.
    Lowe, C.
    Wood, K. M.
    Bacon, C. M.
    LABORATORY INVESTIGATION, 2011, 91 : 298A - 298A
  • [33] Cytogenetic abnormalities in post-transplant lymphoproliferative disorder (PTLD)
    Djokic, M
    Liebowitz, D
    Lebeau, M
    Anastasi, J
    Carlson, K
    LABORATORY INVESTIGATION, 2003, 83 (01) : 230A - 230A
  • [34] OUTCOME OF CHILDREN TREATED FOR RECURRENT EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD)
    Devine, K.
    Seif, A.
    Laskin, B.
    Reilly, A.
    LEUKEMIA RESEARCH, 2022, 121 : S26 - S26
  • [35] Cytogenetic abnormalities in post-transplant lymphoproliferative disorder (PTLD)
    Djokic, M
    Liebowitz, D
    LeBeau, MM
    Anastasi, J
    Carlson, K
    MODERN PATHOLOGY, 2003, 16 (01) : 230A - 230A
  • [36] Epstein barr virus (EBV) negative monomorphic post transplant lymphomas (MPTL).
    Coad, JE
    Jaszez, WB
    Manivel, JC
    LABORATORY INVESTIGATION, 1999, 79 (01) : 134A - 134A
  • [37] Post-transplant Lymphoproliferative Disorder (PTLD): Infection, Cancer?
    Voorhees T.J.
    Baiocchi R.A.
    Current Transplantation Reports, 2016, 3 (2) : 145 - 153
  • [38] Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients
    San-Juan, R.
    Comoli, P.
    Caillard, S.
    Moulin, B.
    Hirsch, H. H.
    Meylan, P.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 : 109 - 118
  • [39] Epstein-Barr Virus DNAemia and post-transplant lymphoproliferative disorder in pediatric solid organ transplant recipients
    Chang, Yeh-Chung
    Young, Rebecca R.
    Mavis, Alisha M.
    Chambers, Eileen T.
    Kirmani, Sonya
    Kelly, Matthew S.
    Kalu, Ibukunoluwa C.
    Smith, Michael J.
    Lugo, Debra J.
    PLOS ONE, 2022, 17 (10):
  • [40] Novel Risk Factors for Epstein-Barr Virus (EBV) Reactivation and Post-Transplant Lymphoproliferative Disorder (PTLD) after Allogeneic Hematopoietic Stem Cell Transplant
    Rodriguez, Lizamarie Bachier
    Shore, Tsiporah B.
    Gergis, Usama
    Hsu, Jingmei
    Phillips, Adrienne A.
    Mayer, Sebastian A.
    Rennert, Hanna
    Van Besien, Koen
    BLOOD, 2017, 130